Mucolipidosis Type Iv Foundation Inc

ATLANTA, GA EIN: 13-3633501 Website

Diseases, Disorders & Medical Disciplines

THE MUCOLIPIDOSIS TYPE IV FOUNDATION OPERATES TO RAISE CONTRIBUTIONS FROM INDIVIDUALS AND COMPANIES IN ORDER TO FUND MEDICAL RESEARCH GRANTS. ALL MEDICAL RESERACH GRANTS ARE PROVIDED TO RESEARCHERS STUDYING THE CAUSE AND SYMPTOMS OF MUCOLIPIDOSIS TYPE IV WITH THE HOPE OF FINDING A CURE FOR THIS DISEASE.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$2.2M

+46.6% YoY

Annual Giving

$2.7M

+1329.7% YoY

Grant Count

+100.0% YoY

Avg Grant Size

$1.3M

+614.8% YoY

About Mucolipidosis Type Iv Foundation Inc

Based on IRS filings

Mucolipidosis Type Iv Foundation Inc is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in ATLANTA, GA. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $2.2M in total assets. In 2024, it awarded 2 grants totaling $2.7M.

Focus Areas

Diseases, Disorders & Medical Disciplines

Ready to take the next step with Mucolipidosis Type Iv Foundation Inc?

Assess fit for your org Draft an LOI Find open RFPs

Geographic Focus

Where this funder awards grants

Grant Distribution by State

Massachusetts $3.7M (100%)

States

Massachusetts

Cities

BostonWorcester

Financial History

Multi-year comparison from IRS filings

Revenue

Expenses

Qualifying Distributions

Net Investment Income

Metric	2024	2023	2022
Total Assets	$2,166,558	$1,477,459	$1,047,509
Revenue	$3,776,356	$1,080,997	$860,271
Expenses	$3,084,160	$656,195	$653,162
Qualifying Distributions	—	—	—
Net Investment Income	—	—	—
Distributable Amount	—	—	—

Giving Over Time

Total grant dollars and number of grants per year

Grant Insights

How this funder distributes its grants

Top Recipients

Top 2 recipients in 2024

Grant Size Distribution

6 grants across all recorded years

Giving History

Grant recipients and amounts by year

Among its reported 2024 grants, the largest include UMass Chan Medical School ($1,948,905), Massachussets General Hospital ($717,237).

Recipient	Purpose	Amount
Massachussets General Hospital Boston, MA	RESEARCH FOR TREATMENT OF ML4 DISEASE	$717,237
UMass Chan Medical School WORCESTER, MA	RESEARCH FOR TREATMENT OF ML4 DISEASE	$1,948,905

Leadership & Key People

Officers and directors from IRS filings

Compensation Overview

From 2024 IRS filing

From 2024 filing

Name	Title	Hours	Compensation
RANDY GOLD	PRESIDENT TREASURER	5	—
CAROLINE GOLD	SECRETARY	2	—
PAULA KUTNER	BOARD MEMBER	2	—
MICHAEL FRIEDMAN	BOARD MEMBER	2	—
DEBRA GOLDSCHMIDT	BOARD MEMBER	2	—
NATHANIEL FERNHOFF	BOARD MEMBER	2	—
REBECCA OBERMAN	EXECUTIVE DIRECTOR	40	$213,815

Subject Areas

Focus areas based on grantmaking activity

Diseases, Disorders & Medical Disciplines

Frequently Asked Questions

What is Mucolipidosis Type Iv Foundation Inc?

Mucolipidosis Type Iv Foundation Inc is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in ATLANTA, GA. It holds $2.2M in total assets as of 2024.

How large is Mucolipidosis Type Iv Foundation Inc?

As of 2024, Mucolipidosis Type Iv Foundation Inc holds $2.2M in total assets with $3.8M in annual revenue. It awarded 2 grants totaling $2.7M in 2024.

Where does Mucolipidosis Type Iv Foundation Inc operate?

Mucolipidosis Type Iv Foundation Inc has awarded grants in Massachusetts.

What size grants does Mucolipidosis Type Iv Foundation Inc award?

In 2024, Mucolipidosis Type Iv Foundation Inc awarded 2 grants totaling $2.7M — an average of about $1.3M per grant, based on its IRS Form 990 filings.

What is Mucolipidosis Type Iv Foundation Inc's EIN?

Mucolipidosis Type Iv Foundation Inc's EIN (Employer Identification Number) is 13-3633501. IRS Form 990 filing data is available on this page for 2020–2024.